Impel Pharmaceuticals Inc logo

Impel Pharmaceuticals Inc Share Price Today (NASDAQ: IMPL)

Impel Pharmaceuticals Inc share price is $0 & ₹0.00 as on 19 Dec 2023 IST

▲

-0.04

(-100%)

Market is closed - opens 7 PM, 14 Jul 2025

Bell Icon

The stock has been delisted from the stock exchange on 20 Dec 2023

View live Impel Pharmaceuticals Inc share price in Dollar and Rupees. Guide to invest in Impel Pharmaceuticals Inc stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Impel Pharmaceuticals Inc, along with analyst recommendations, forecasts, and comprehensive financials.

Impel Pharmaceuticals Inc (IMPL) Key Statistics

in dollars & INR

Previous Close
$0.04
Open
$0.045
Market Capitalization
$1.3M
Today's Volume
$720.0K
Revenue TTM
$21.0M
EBITDA
$-69.0M
Earnings Per Share (EPS)
$-3.12
Dividend Yield
0.0%
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-2546.09%

How to invest in Impel Pharmaceuticals Inc Stock (IMPL) from India?

It is very easy for Indian residents to invest directly in Impel Pharmaceuticals Inc from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Impel Pharmaceuticals Inc stock in both Indian Rupees (INR) and US Dollars (USD). Search for Impel Pharmaceuticals Inc or IMPL on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Impel Pharmaceuticals Inc or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Impel Pharmaceuticals Inc shares which would translate to null fractional shares of Impel Pharmaceuticals Inc as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Impel Pharmaceuticals Inc, in just a few clicks!

Global Institutional Holdings in Impel Pharmaceuticals Inc

  • Kohlberg Kravis Roberts & Co LP

    17.31%

  • NVP Associates LLC

    12.88%

  • Vivo Capital, LLC

    12.07%

  • 5AM Venture Management, LLC

    12.07%

  • venBio Partners LLC

    11.55%

  • Vanguard Group Inc

    2.11%

Analyst Recommendation on Impel Pharmaceuticals Inc

Rating
Trend

Buy

    75%Buy

    25%Hold

    0%Sell

Based on 8 Wall street analysts offering stock ratings for Impel Pharmaceuticals Inc(by analysts ranked 0 to 5 stars)

About Impel Pharmaceuticals Inc

Impel Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapies for patients suffering from central nervous system disease in the United States. Its lead product candidate is Trudhesa, an upper nasal formulation of dihydroergotamine for the acute treatment of migraine. Impel Pharmaceuticals Inc. was formerly known as Impel NeuroPharma, Inc. and changed its name to Impel Pharmaceuticals Inc. in April 2022. The company was incorporated in 2008 and is headquartered in Seattle, Washington.
Organization
Impel Pharmaceuticals Inc
Employees
160
CEO
Mr. Adrian Adams
Industry
Miscellaneous

Important FAQs about investing in IMPL Stock from India :

Can Indians buy Impel Pharmaceuticals Inc shares?

Yes, Indians can invest in the Impel Pharmaceuticals Inc (IMPL) from India.

With INDmoney, you can buy Impel Pharmaceuticals Inc at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Impel Pharmaceuticals Inc at zero transaction cost.

How can I buy Impel Pharmaceuticals Inc shares from India?

It is very easy to buy Impel Pharmaceuticals Inc from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Impel Pharmaceuticals Inc (IMPL) be purchased?

Yes, you can buy fractional shares of Impel Pharmaceuticals Inc with INDmoney app.

What are the documents required to start investing in Impel Pharmaceuticals Inc stocks?

To start investing in Impel Pharmaceuticals Inc, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What is today's market capitalisation of Impel Pharmaceuticals Inc?

Today's market capitalisation of Impel Pharmaceuticals Inc IMPL is 1.3M

Who is the Chief Executive Officer (CEO) of Impel Pharmaceuticals Inc ?

Mr. Adrian Adams is the current Chief Executive Officer (CEO) of Impel Pharmaceuticals Inc.